Equity Analysis

Quarterly Results

    Vivimed Labs Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532660
    INE526G01021
    7.4280394
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    VIVIMEDLAB
    0
    40.63
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    2
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales37.1430.2833.00
Other Operating Income0.000.000.00
Other Income 0.042.160.01
Total Income37.1732.4433.01
Total Expenditure 36.2535.6933.29
PBIDT0.92-3.25-0.28
Interest 13.1611.8210.61
PBDT-12.24-15.07-10.90
Depreciation4.494.494.49
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.550.000.00
Reported Profit After Tax-16.17-19.56-15.38
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-16.17-19.56-15.38
EPS (Unit Curr.)-1.95-2.36-1.86
EPS (Adj) (Unit Curr.)-1.95-2.36-1.86
Calculated EPS (Unit Curr.)-1.95-2.36-1.86
Calculated EPS (Adj) (Unit Curr.)-1.95-2.36-1.86
Calculated EPS (Ann.) (Unit Curr.)-7.80-9.44-7.42
Calculated EPS (Adj) (Ann.) (Unit Curr.)-7.80-9.44-7.42
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity16.5816.5816.58
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)2.48-10.73-0.85
PBDTM(%)-32.96-49.77-33.03
PATM(%)-43.54-64.60-46.61
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-1.89-2.29-1.86